Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: New Pacers: T3: Case Reassigned to J Grewal.. & Case Mgmt Conf Dates 8-15-12

You wrote: "Case Management Statement due by 8/21/2012."

Also, this mentioned date and statement comes a week before the 28th date. It could be informative about what has been going on, where the case stands now and where it may be heading. I guess it would be from the courts perspective?

And as you stated, it would be nice if someone could attend on the 28th. My guess is there will be some one(s) [or there representatives] there who have a significant number of PTSC shares. Are those the people that would report back to this message board?

( Who are the major shareholders these days anyway? Do you think those fighting us are also buying shares in case the rulings are going against them? )

If any agoracom members are close by and have the time and interest to offer their perspective that would be much appreciated. TIA

Share
New Message
Please login to post a reply